(Q40414550)

20 September 2017

title

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases (English)

1 reference

20 September 2017

1 reference

Julie King

1

1 reference

20 September 2017

Richard Quinn

2

1 reference

20 September 2017

Derek M Glenn

3

1 reference

20 September 2017

Julia Janssen

4

1 reference

20 September 2017

Denise Tong

5

1 reference

20 September 2017

Winston Liaw

6

1 reference

20 September 2017

David L Morris

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

20 September 2017

1 reference

20 September 2017

volume

113

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

921-929

1 reference

Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

Transcatheter chemoembolization of progressive carcinoid liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

The management of patients with advanced carcinoid tumors and islet cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

Hepatic neuroendocrine metastases: does intervention alter outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Liver transplantation for neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Neuroendocrine hepatic metastases: does aggressive management improve survival?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Chemotherapy in the treatment of neuroendocrine malignant tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Apudomas metastatic to the liver: treatment by hepatic artery embolization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Radioembolization with 90Y microspheres: angiographic and technical considerations.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23685

7 January 2021

Identifiers

DOI

10.1002/CNCR.23685

1 reference

20 September 2017

1 reference